QualityStocksNewsBreaks Archives - Page 1238 of 1451

TuesdayNov 20, 2018 12:23 pm

QualityStocksNewsBreaks – Green Hygienics Holdings Inc.’s (GRYN) Cannagram Services to Drive Vertical Expansion

Green Hygienics Holdings (OTC: GRYN), a full-scope, premium cannabis company, sees its rebranded Cannagram Services as a key platform to generate strategic growth in vertical markets. An article discussing the company reads, “Cannagram Services, CoursePro Academy and Myijuana together advance GRYN’s strategy of expanding its product sales and exposure in the full-scope premium cannabis industry, targeting the top-end medical and adult-use recreational markets. Science-driven cannabis growing methods are linked to its proprietary systems, algorithms, software and customized hardware. In a commercial environment, GRYN uses hybrid-aeroponics cultivation to produce pharmaceutical grade cannabis at a high yield and low cost.” To view…

TuesdayNov 20, 2018 12:17 pm

QualityStocksNewsBreaks – Why Plus Products Inc. (CSE: PLUS) is “One to Watch”

Plus Products (CSE: PLUS) is a branded cannabis-infused products manufacturer headquartered in San Mateo, California. The company focusses on creating edibles using extracts to ensure compliant, consistent products. A recent article discussing the company reads, “Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up…

TuesdayNov 20, 2018 9:56 am

QualityStocksNewsBreaks – Marijuana Company of America Inc. (MCOA) Reports Q3 Financial Results, Revenue Trend

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) this morning announced financial results for the three and nine months ended September 30, 2018. The update noted the following highlights from Q3 2017 to Q3 2018: Increased revenues of 2984 percent; increased total assets by 42 percent; operations net loss decrease of 1057 percent; decrease in SG&A expenses by 1007 percent; and decrease in total liabilities by 259 percent. “The third quarter marked an important milestone for MCOA, as our hempSMART sales have ramped up due to our multi-pronged marketing campaign and several newly launched products,” MCOA CEO…

TuesdayNov 20, 2018 9:49 am

QualityStocksNewsBreaks – CytoDyn Inc.’s (CYDY) PRO 140 Assigned Leronlimab as Official Name by USAN Council

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) today announced that the United States Adopted Names (“USAN”) Council has designated leronlimab as the official name for its PRO 140. The investigational new drug has not yet been approved for any indication; however, CytoDyn is exploring partnering and licensing agreements for HIV treatment with intention to pursue use of leronlimab in cancer and other autoimmune diseases. “As we recently announced, we are very pleased with the results of our monotherapy higher dose of leronlimab 700 mg showing an impressive responder’s rate of over 90%,” CytoDyn President and Chief Executive Officer Dr. Nader Pourhassan…

TuesdayNov 20, 2018 9:20 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) President and CEO Featured in Uptick Newswire’s Stock Day Podcast

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences industry, this morning announced the featured interview of its president and CEO Richard T. Schumacher with Stock Day’s Everett Jolly. Among other highlights, Schumacher announced that the company has accomplished yet another important milestone in the advancement of its proprietary Ultra Shear Technology (“UST”) platform and commercialization program. Following the company’s recent news regarding the development of the first working prototype of the UST system, PBIO reported that it has developed a proprietary method…

MondayNov 19, 2018 1:38 pm

QualityStocksNewsBreaks – Youngevity International, Inc. (NASDAQ: YGYI) Founder Featured in Documentary

Leading omni-direct lifestyle company Youngevity International, Inc. (NASDAQ: YGYI) this morning announced Carpe Canum Media’s release of a documentary featuring YGYI's founder titled "The Audacity of Health: The Dr. Joel Wallach Story." The documentary follows Wallach's life and career, from early work in the 1960s in studying one of the first mass (animal) pollution-related die-offs and helping to save Africa’s white rhino, to his work in the 70s while discovering the correlation between disease and nutritional deficiencies in animals, as well as how the parallel extends to humans. The story also features Wallach's successful FDA petition to include specific nutrients…

MondayNov 19, 2018 11:57 am

QualityStocksNewsBreaks – Global Payout, Inc.’s (GOHE) MTrac Platform Receives with Positive Feedback and Enthusiasm at MJBizCon 2018

Global Payout Inc. (OTC: GOHE), together with wholly owned subsidiary MTrac Tech Corp., this morning highlighted the overwhelming success of its participation at this year’s MJBizCon. Per the update, the MTrac team secured innumerous significant leads with prospective new clients and formed potential industry-leading partnerships over the course of the three-day event in Las Vegas. MTrac’s streamlined, compliant platform was met with positive feedback and enthusiasm, signifying its status as a solution that the industry desperately needs. “The reception of the product by the attendees at the conference was impressive and truly mind blowing at times,” Global Payout CRO Aaron…

MondayNov 19, 2018 11:43 am

QualityStocksNewsBreaks – DPW Holdings, Inc.’s (NYSE American: DPW) Expansion Plan with IAM, Inc. Targets New Locations in 2019, Active Multi-Year Growth

DPW Holdings, Inc. (NYSE American: DPW) this morning announced an agreement with subsidiary IAM, Inc., owner of the Prep Kitchen brand of restaurants, to add up to four San Diego locations in 2019 and initiate an active growth plan over the coming years. The program aims to expand the Prep Kitchen restaurant brand and promote future inclusion of other restaurant concepts. “DPW seeks assets with significant promise,” DPW CEO and Chairman Milton “Todd” Ault III stated in the news release. “With strong hospitality leadership, IAM, Inc. and Prep Kitchen is positioned to capitalize on the exploding San Diego market. This…

MondayNov 19, 2018 11:01 am

QualityStocksNewsBreaks – First Cobalt Corp.’s (TSX.V: FCC) (OTCQX: FTSSF) Flagship Iron Creek Project Shows Continuity of Mineralization

Vertically integrated North American pure-play cobalt company First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) this morning announced drill results from its Idaho-based Iron Creek Cobalt Project that extend mineralization at depth and demonstrate additional mineralization between the two known zones and within the Waite Zone footwall. Highlights of the report reflect continued broad widths of high grade mineralization in the eastern portion of the current resource area; massive sulphide intercepts between the main zones; and extended mineralization to an additional 50 meters below the central portion of the current resource area at grades comparable to the resource estimate.…

MondayNov 19, 2018 10:50 am

QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) to Present Bria-IMT Clinical Data at San Antonio Breast Cancer Symposium

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatment options for cancer, this morning announced that its Bria-IMT will be featured in a poster session during this year’s San Antonio Breast Cancer Symposium (“SABCS”), to be held December 4-8, 2018, in San Antonio, Texas. The poster highlights data on Bria-IMT’s use as a monotherapy demonstrating positive proof-of-concept, as well as an initial safety and tolerability assessment for its use in combination with pembrolizumab [KEYTRUDA - manufactured by Merck & Co., Inc. (NYSE: MRK)] for advanced breast cancer. Thomas Jefferson University assistant professor of medical oncology…

Site Search

Company Search

Category: QualityStocksNewsBreaks